Medicus Pharma Ltd is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with unmet medical needs. The company specializes in creating drugs that target specific disease mechanisms, particularly in the fields of oncology and rare diseases. By leveraging advanced research and development techniques, Medicus Pharma aims to offer transformative treatment options that improve patient outcomes and enhance quality of life. Collaborating with leading researchers and healthcare institutions, the company is committed to advancing medical science and addressing complex health challenges. Read More
The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is driving a surge in chronic diseases such as cancer, autoimmune disorders, and cardiovascular conditions. At the same time, breakthroughs in biomedical research are enabling the development of targeted, more effective therapies, transforming treatment approaches in both human and veterinary medicine.
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Dr. Raza Bokhari, Company’s Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 Years
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
